VISUALIZER

T03 is a newly licensed non-steroidal anti-inflammatory drug. The dose you chose is based on the standard dose recommended by the manufacturer, 75mg twice a day. It is a relatively well absorbed drug with an average bioavailability of about 90%. It is primarily cleared by hepatic metabolism, with no active metabolites. Its plasma elimination half-life is approximately 6-8 hours. Large scale clinical trials suggest that analgesic effects are on average observable at plasma concentrations exceeding 2.5mg/L, while anti-inflammatory effects require peak concentrations of at least 5mg/L. Plasma concentrations greater than 7mg/L may be associated with a higher risk of hepatoxicity.